Article
Unveiling the Anticancer Mechanisms of Prodigiosin by inhibiting of CDK1, TOP2A, and AURKB Expression in Cervical Carcinoma
2024-01-25
Abstract excerpt
Prodigiosin (PG) demonstrates a selective targeting effect on tumor cells. However, its role in cervical carcinoma is still being studied. In this study, we aim to study the specific targets and mechanism of PG in cervical carcinoma. We employed GO enrichment and KEGG analysis to identify core genes in CC patients. To corroborate the expression levels of these core genes, we used staining and RT-PCR on both normal...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8a89c90f-8d21-590a-9e46-ab24bf21fe0c
- DOI
- 10.21203/rs.3.rs-3829039/v1
